vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Paymentus Holdings, Inc. (PAY). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $330.5M, roughly 1.5× Paymentus Holdings, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.3%, a 0.6% gap on every dollar of revenue. On growth, Paymentus Holdings, Inc. posted the faster year-over-year revenue change (28.1% vs -1.7%). Over the past eight quarters, Paymentus Holdings, Inc.'s revenue compounded faster (33.7% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Paymentus Holdings, Inc. is a leading cloud-based bill payment and customer engagement technology provider. It offers integrated digital payment solutions, billing automation tools, and self-service portals for enterprises across utilities, financial services, government, healthcare, and telecommunications segments, primarily operating in the North American market.
MD vs PAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $330.5M |
| Net Profit | $33.7M | $20.7M |
| Gross Margin | — | 25.4% |
| Operating Margin | 9.9% | 7.3% |
| Net Margin | 6.8% | 6.3% |
| Revenue YoY | -1.7% | 28.1% |
| Net Profit YoY | 10.5% | 57.2% |
| EPS (diluted) | $0.40 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $330.5M | ||
| Q3 25 | $492.9M | $310.7M | ||
| Q2 25 | $468.8M | $280.1M | ||
| Q1 25 | $458.4M | $275.2M | ||
| Q4 24 | $502.4M | $257.9M | ||
| Q3 24 | $511.2M | $231.6M | ||
| Q2 24 | $504.3M | $197.4M | ||
| Q1 24 | $495.1M | $184.9M |
| Q4 25 | $33.7M | $20.7M | ||
| Q3 25 | $71.7M | $17.7M | ||
| Q2 25 | $39.3M | $14.7M | ||
| Q1 25 | $20.7M | $13.8M | ||
| Q4 24 | $30.5M | $13.1M | ||
| Q3 24 | $19.4M | $14.4M | ||
| Q2 24 | $-153.0M | $9.4M | ||
| Q1 24 | $4.0M | $7.2M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 25.5% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | 28.5% |
| Q4 25 | 9.9% | 7.3% | ||
| Q3 25 | 13.8% | 6.4% | ||
| Q2 25 | 12.8% | 5.7% | ||
| Q1 25 | 7.0% | 5.7% | ||
| Q4 24 | 7.8% | 5.5% | ||
| Q3 24 | 6.6% | 5.2% | ||
| Q2 24 | -31.3% | 5.2% | ||
| Q1 24 | 3.2% | 4.5% |
| Q4 25 | 6.8% | 6.3% | ||
| Q3 25 | 14.5% | 5.7% | ||
| Q2 25 | 8.4% | 5.3% | ||
| Q1 25 | 4.5% | 5.0% | ||
| Q4 24 | 6.1% | 5.1% | ||
| Q3 24 | 3.8% | 6.2% | ||
| Q2 24 | -30.3% | 4.7% | ||
| Q1 24 | 0.8% | 3.9% |
| Q4 25 | $0.40 | $0.16 | ||
| Q3 25 | $0.84 | $0.14 | ||
| Q2 25 | $0.46 | $0.11 | ||
| Q1 25 | $0.24 | $0.11 | ||
| Q4 24 | $0.37 | $0.11 | ||
| Q3 24 | $0.23 | $0.11 | ||
| Q2 24 | $-1.84 | $0.07 | ||
| Q1 24 | $0.05 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $320.9M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $560.4M |
| Total Assets | $2.2B | $667.9M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $320.9M | ||
| Q3 25 | $340.1M | $287.9M | ||
| Q2 25 | $224.7M | $266.4M | ||
| Q1 25 | $99.0M | $245.8M | ||
| Q4 24 | $229.9M | $205.9M | ||
| Q3 24 | $103.8M | $187.5M | ||
| Q2 24 | $19.4M | $188.8M | ||
| Q1 24 | $8.0M | $180.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $560.4M | ||
| Q3 25 | $890.7M | $537.4M | ||
| Q2 25 | $833.8M | $516.7M | ||
| Q1 25 | $789.2M | $500.4M | ||
| Q4 24 | $764.9M | $485.6M | ||
| Q3 24 | $732.5M | $468.8M | ||
| Q2 24 | $706.5M | $451.6M | ||
| Q1 24 | $856.2M | $439.4M |
| Q4 25 | $2.2B | $667.9M | ||
| Q3 25 | $2.2B | $644.4M | ||
| Q2 25 | $2.1B | $609.5M | ||
| Q1 25 | $2.0B | $590.9M | ||
| Q4 24 | $2.2B | $576.2M | ||
| Q3 24 | $2.1B | $552.9M | ||
| Q2 24 | $2.0B | $527.7M | ||
| Q1 24 | $2.2B | $514.0M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $45.1M |
| Free Cash FlowOCF − Capex | — | $45.0M |
| FCF MarginFCF / Revenue | — | 13.6% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.18× |
| TTM Free Cash FlowTrailing 4 quarters | — | $161.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $45.1M | ||
| Q3 25 | $137.3M | $35.1M | ||
| Q2 25 | $137.2M | $31.5M | ||
| Q1 25 | $-117.5M | $50.4M | ||
| Q4 24 | $133.0M | $27.9M | ||
| Q3 24 | $91.8M | $6.7M | ||
| Q2 24 | $107.0M | $18.0M | ||
| Q1 24 | $-125.2M | $11.0M |
| Q4 25 | — | $45.0M | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $50.4M | ||
| Q4 24 | — | $27.8M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $17.8M | ||
| Q1 24 | — | $10.8M |
| Q4 25 | — | 13.6% | ||
| Q3 25 | — | 11.3% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | — | 5.9% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 3.39× | 2.18× | ||
| Q3 25 | 1.91× | 1.98× | ||
| Q2 25 | 3.49× | 2.14× | ||
| Q1 25 | -5.66× | 3.65× | ||
| Q4 24 | 4.36× | 2.12× | ||
| Q3 24 | 4.72× | 0.47× | ||
| Q2 24 | — | 1.93× | ||
| Q1 24 | -31.03× | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PAY
| Payment Transaction Processing Revenue | $326.9M | 99% |
| Other | $3.5M | 1% |
